Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Penta Valent Tbk. (PEVE) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Penta Valent Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Penta Valent Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 42.6K 24h volume), while Penta Valent Tbk. trades at Rp312 (market cap 547.34B, 371.6K 24h volume). The key difference: Penta Valent Tbk. is the larger of the two by market cap, and Penta Valent Tbk. is more actively traded (371.6K versus 42.6K). Which is the better fit depends on your goals.

DGNSPEVE
Market Cap
308B547.34B
Volume
42.6K371.6K
Lot
4263.72K
Turnover
9.61M114.73M
Average Price
225.66308.74
Value
9.61M114.73M
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
110

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
PEVE
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Penta Valent Tbk.

PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.

Read more on PEVE